A shadow market for unlicensed slimming medications is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.
Experimental Treatment Gaining Popularity Via Social Media
The experimental drug, which remains in research studies, is being advertised by social media influencers for its alleged weight-reducing properties. Viewers are encouraged to contact these profiles privately for source information, while also obtaining discount codes.
Active Trade on Social Networks
Additionally, a flourishing market exists on messaging services, where communities with thousands of members share comparison images, administration instructions and claims of next-day British shipping. Vendors market the substance there before directing buyers to other platforms for transactions.
Understanding The Experimental Drug
This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help patients lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.
Healthcare Experts Voice Worries
However, physicians and pharmacists have warned that the sale of what is still an unlicensed drug in the UK is a cause for concern and could lead to users injecting substances of uncertain source.
Several professionals said the demand for retatrutide could be linked to the rising cost of approved slimming products such as Mounjaro.
Legal Position and Enforcement
Marketing retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unapproved medication that must not be marketed or distributed for human use under the British medical regulations.
Some influencers try to circumvent the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still violate pharmaceutical, marketing, and consumer laws, potentially leading to fines, legal action or prison.
Service Reaction and Content Removal
Based on TikTok, the service has removed problematic material and banned related hashtags and search suggestions. The organization said it was committed to maintaining the platform secure and investing in enhancing enforcement strategies.
Online Trading Operations
Research also discovered communities with up to 9,000 members marketing the experimental drug using the platform's integrated discovery tool, which operates like a public directory. Typing “retatrutide” instantly displays groups with thousands of users, populated with photos of slimming results, positive reviews and detailed guides for mixing or administering at residence.
After minutes of entering one community, a seller posted contact information, where most transactions take place. The seller provided an instruction manual and promised delivery within two days. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. Not one asked about body mass, medical conditions or previous experience.
Item Details and Pricing
Inside these groups, messages show dark colored parcels with postal service labels, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, prepared at residence with purified liquid, or ready-to-use injectors usually priced at 160 pounds for 20 milligrams. When questioned how long a pen should last, sellers give contradictory responses varying between a several days to “depends on your body”.
Service Oversight and Security Actions
A spokesperson for Telegram said it actively monitored harmful content on its service including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Medical Expert Warnings
“Individuals are administering substances they cannot confirm. Even if the science behind this drug is valid, these online products may not include what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of an online medical service linked the increase in interest to current price rises for authorized weight-loss medications such as Mounjaro. “With costs rising, individuals are turning to online platforms. But counterfeit injections are extremely risky. You cannot know what’s inside or whether the environment they were made in was sterile,” she explained.
Her staff has already seen patients harmed by personal administration from unverified suppliers. “We understand the frustration, but buying from messaging apps or WhatsApp is taking chances with your health,” said the doctor. “These substances could be impure or improperly measured.”
Manufacturer Position
A spokesperson from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been evaluated or authorized by any government authority globally. “Therefore at this time no one can sell [it] for human use,” they said, adding that any item “falsely representing itself as a Lilly investigational product not yet approved … may expose patients to possibly serious medical dangers”.
